Trial Profile
A treatment protocol for patients continuing from a prior SU011248 protocol
Status:
Not stated
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 13 Mar 2006
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 13 Mar 2006 New trial record.